{"product_id":"methylene-blue-60ml-usp-grade","title":"Methylene blue USP grade 100x10mg","description":"\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e                                          \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003eFOR HUMAN \u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003eCONSUMPTION\u003cmeta charset=\"UTF-8\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"48\" data-end=\"681\"\u003e\u003cstrong\u003eMethylene blue\u003c\/strong\u003e is a phenothiazine \u003cstrong data-start=\"120\" data-end=\"133\"\u003eredox dye\u003c\/strong\u003e with multiple pharmacologies. Clinically it’s \u003cstrong data-start=\"180\" data-end=\"227\"\u003eFDA-approved for acquired methemoglobinemia\u003c\/strong\u003e (it accepts electrons from NADPH-methemoglobin reductase as \u003cstrong data-start=\"288\" data-end=\"311\"\u003eleucomethylene blue\u003c\/strong\u003eand reduces Fe³⁺→Fe²⁺ to restore O₂ carriage). Beyond this, MB \u003cstrong data-start=\"375\" data-end=\"444\"\u003einhibits nitric-oxide synthase and soluble guanylyl cyclase (sGC)\u003c\/strong\u003e (countering pathologic vasodilation), acts as a \u003cstrong data-start=\"493\" data-end=\"512\"\u003ephotosensitizer\u003c\/strong\u003e for antimicrobial photodynamic therapy (aPDT), \u003cstrong data-start=\"560\" data-end=\"598\"\u003eshuttles electrons in mitochondria\u003c\/strong\u003e, and is a \u003cstrong data-start=\"609\" data-end=\"646\"\u003epotent reversible MAO-A inhibitor\u003c\/strong\u003e (important for drug interactions).\u003c\/p\u003e\n\u003chr data-start=\"683\" data-end=\"686\"\u003e\n\u003ch3 data-start=\"688\" data-end=\"753\"\u003eAdditional Benefits of Methylene Blue Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"755\" data-end=\"3342\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"755\" data-end=\"783\"\u003e\n\u003ctr data-start=\"755\" data-end=\"783\"\u003e\n\u003cth data-start=\"755\" data-end=\"765\" data-col-size=\"md\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-start=\"765\" data-end=\"783\" data-col-size=\"xl\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"794\" data-end=\"3342\"\u003e\n\u003ctr data-start=\"794\" data-end=\"1121\"\u003e\n\u003ctd data-start=\"794\" data-end=\"844\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"796\" data-end=\"843\"\u003e1 Vasoplegic shock rescue (sepsis\/post-CPB)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"844\" data-end=\"1121\" data-col-size=\"xl\"\u003eIV MB can \u003cstrong data-start=\"856\" data-end=\"899\"\u003eraise MAP and reduce catecholamine dose\u003c\/strong\u003e by blocking \u003cstrong data-start=\"912\" data-end=\"927\"\u003eNO–sGC–cGMP\u003c\/strong\u003e signalling; early use in \u003cstrong data-start=\"953\" data-end=\"967\"\u003evasoplegia\u003c\/strong\u003e (post-cardiac surgery, septic shock) shows hemodynamic benefit in RCTs\/series; mortality data remain mixed. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Critical Care; Anesthesiology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1122\" data-end=\"1403\"\u003e\n\u003ctd data-start=\"1122\" data-end=\"1164\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1124\" data-end=\"1163\"\u003e2 Ifosfamide-induced encephalopathy\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1164\" data-end=\"1403\" data-col-size=\"xl\"\u003eCase series and protocols support \u003cstrong data-start=\"1200\" data-end=\"1223\"\u003e1–2 mg\/kg IV q4–8 h\u003c\/strong\u003e to reverse neurotoxicity, likely via \u003cstrong data-start=\"1261\" data-end=\"1281\"\u003eredox re-routing\u003c\/strong\u003e (NAD⁺\/NADH) and \u003cstrong data-start=\"1298\" data-end=\"1330\"\u003emonoamine oxidase modulation\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Clinical Oncology; Supportive Care in Cancer\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1404\" data-end=\"1730\"\u003e\n\u003ctd data-start=\"1404\" data-end=\"1448\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1406\" data-end=\"1447\"\u003e3 Tau aggregation \u0026amp; neurodegeneration\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1448\" data-end=\"1730\" data-col-size=\"xl\"\u003eMB\/LMTM (leuco-methylthioninium) \u003cstrong data-start=\"1483\" data-end=\"1511\"\u003einhibits tau aggregation\u003c\/strong\u003e and supports \u003cstrong data-start=\"1525\" data-end=\"1541\"\u003emitochondria\u003c\/strong\u003e; Alzheimer’s trials show \u003cstrong data-start=\"1567\" data-end=\"1585\"\u003emixed outcomes\u003c\/strong\u003e (signals in monotherapy subsets), with dosing\/formulation under refinement. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Alzheimer’s Disease; The Lancet Neurology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1731\" data-end=\"2014\"\u003e\n\u003ctd data-start=\"1731\" data-end=\"1778\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1733\" data-end=\"1777\"\u003e4 Mitochondrial rescue \u0026amp; neuroprotection\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1778\" data-end=\"2014\" data-col-size=\"xl\"\u003eAt low doses, MB \u003cstrong data-start=\"1797\" data-end=\"1830\"\u003ebypasses complex I\/III blocks\u003c\/strong\u003e, improves \u003cstrong data-start=\"1841\" data-end=\"1859\"\u003eATP generation\u003c\/strong\u003e, reduces ROS, and shows \u003cstrong data-start=\"1884\" data-end=\"1918\"\u003eretinal\/optic-nerve protection\u003c\/strong\u003e in models and small studies. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;PNAS; Investigative Ophthalmology \u0026amp; Visual Science\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2015\" data-end=\"2344\"\u003e\n\u003ctd data-start=\"2015\" data-end=\"2065\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2017\" data-end=\"2064\"\u003e5 Antimicrobial photodynamic therapy (aPDT)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2065\" data-end=\"2344\" data-col-size=\"xl\"\u003e\n\u003cstrong data-start=\"2067\" data-end=\"2092\"\u003eMB + 630–670 nm light\u003c\/strong\u003e produces singlet oxygen, killing \u003cstrong data-start=\"2126\" data-end=\"2152\"\u003eplanktonic and biofilm\u003c\/strong\u003e bacteria (including MRSA\/\u003cem data-start=\"2178\" data-end=\"2193\"\u003eP. aeruginosa\u003c\/em\u003e) and fungi; used in \u003cstrong data-start=\"2214\" data-end=\"2248\"\u003echronic wounds, dentistry, ENT\u003c\/strong\u003e pilots. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Antimicrobial Agents \u0026amp; Chemotherapy; Journal of Clinical Periodontology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2345\" data-end=\"2629\"\u003e\n\u003ctd data-start=\"2345\" data-end=\"2398\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2347\" data-end=\"2397\"\u003e6 Antimalarial partner \u0026amp; transmission-blocking\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"2398\" data-end=\"2629\"\u003eAdded to artemisinin regimens, MB \u003cstrong data-start=\"2434\" data-end=\"2458\"\u003elowers gametocytemia\u003c\/strong\u003e and may reduce transmission; GI\/urine discoloration and \u003cstrong data-start=\"2515\" data-end=\"2546\"\u003eG6PD-related hemolysis risk\u003c\/strong\u003e require screening. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;The Lancet Infectious Diseases; Malaria Journal\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2630\" data-end=\"2867\"\u003e\n\u003ctd data-start=\"2630\" data-end=\"2677\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2632\" data-end=\"2676\"\u003e7 Dermatologic\/anti-photoaging (topical)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"2677\" data-end=\"2867\"\u003eMB creams show \u003cstrong data-start=\"2694\" data-end=\"2721\"\u003efibroblast rejuvenation\u003c\/strong\u003e, ↑ collagen genes, ↓ senescence markers, and \u003cstrong data-start=\"2767\" data-end=\"2798\"\u003eimproved hydration\/wrinkles\u003c\/strong\u003e in small trials. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Redox Biology; Dermatologic Therapy\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2868\" data-end=\"3051\"\u003e\n\u003ctd data-start=\"2868\" data-end=\"2905\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2870\" data-end=\"2904\"\u003e8 Refractory ischemic priapism\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"2905\" data-end=\"3051\"\u003eIntracavernosal MB \u003cstrong data-start=\"2926\" data-end=\"2945\"\u003einhibits NO–sGC\u003c\/strong\u003e, offering \u003cstrong data-start=\"2956\" data-end=\"2966\"\u003erescue\u003c\/strong\u003e when alpha-agonists fail before shunting. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Urology; BJU International\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3052\" data-end=\"3342\"\u003e\n\u003ctd data-start=\"3052\" data-end=\"3088\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"3054\" data-end=\"3087\"\u003e9 Peri-anaphylaxis vasoplegia\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"3088\" data-end=\"3342\"\u003eAs adjunct in \u003cstrong data-start=\"3104\" data-end=\"3130\"\u003erefractory hypotension\u003c\/strong\u003e after anaphylaxis or spinal anesthesia, MB can restore \u003cstrong data-start=\"3186\" data-end=\"3203\"\u003evascular tone\u003c\/strong\u003e via \u003cstrong data-start=\"3208\" data-end=\"3224\"\u003esGC blockade\u003c\/strong\u003e; evidence largely from series. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Annals of Allergy, Asthma \u0026amp; Immunology; British Journal of Anaesthesia\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"3344\" data-end=\"3347\"\u003e\n\u003ch2 data-start=\"3349\" data-end=\"3384\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-start=\"3386\" data-end=\"3419\"\u003e2.1 Target Pharmacodynamics\u003c\/h3\u003e\n\u003cul data-start=\"3420\" data-end=\"3990\"\u003e\n\u003cli data-start=\"3420\" data-end=\"3546\"\u003e\n\u003cp data-start=\"3422\" data-end=\"3546\"\u003e\u003cstrong data-start=\"3422\" data-end=\"3444\"\u003eRBC redox cycling:\u003c\/strong\u003e MB ⇄ leucomethylene blue accepts electrons from \u003cstrong data-start=\"3493\" data-end=\"3518\"\u003eNADPH-MetHb reductase\u003c\/strong\u003e, reducing \u003cstrong data-start=\"3529\" data-end=\"3543\"\u003eMetHb → Hb\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3547\" data-end=\"3657\"\u003e\n\u003cp data-start=\"3549\" data-end=\"3657\"\u003e\u003cstrong data-start=\"3549\" data-end=\"3567\"\u003eVascular tone:\u003c\/strong\u003e \u003cstrong data-start=\"3568\" data-end=\"3594\"\u003eNOS and sGC inhibition\u003c\/strong\u003e ↓ cGMP → \u003cstrong data-start=\"3604\" data-end=\"3640\"\u003ereverses pathologic vasodilation\u003c\/strong\u003e in vasoplegia.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3658\" data-end=\"3768\"\u003e\n\u003cp data-start=\"3660\" data-end=\"3768\"\u003e\u003cstrong data-start=\"3660\" data-end=\"3681\"\u003eMAO-A inhibition:\u003c\/strong\u003e Potent, reversible inhibition → \u003cstrong data-start=\"3714\" data-end=\"3741\"\u003eserotonin-syndrome risk\u003c\/strong\u003e with serotonergic drugs.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3769\" data-end=\"3889\"\u003e\n\u003cp data-start=\"3771\" data-end=\"3889\"\u003e\u003cstrong data-start=\"3771\" data-end=\"3806\"\u003eMitochondrial electron shuttle:\u003c\/strong\u003e Accepts\/donates electrons between \u003cstrong data-start=\"3841\" data-end=\"3864\"\u003eNADH ↔ cytochrome c\u003c\/strong\u003e, bypassing ETC blocks.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3890\" data-end=\"3990\"\u003e\n\u003cp data-start=\"3892\" data-end=\"3990\"\u003e\u003cstrong data-start=\"3892\" data-end=\"3912\"\u003ePhotosensitizer:\u003c\/strong\u003e Upon \u003cstrong data-start=\"3918\" data-end=\"3931\"\u003ered-light\u003c\/strong\u003e activation, generates \u003cstrong data-start=\"3954\" data-end=\"3976\"\u003esinglet oxygen\/ROS\u003c\/strong\u003e for \u003cstrong data-start=\"3981\" data-end=\"3989\"\u003eaPDT\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"3992\" data-end=\"4019\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"4021\" data-end=\"4474\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"4021\" data-end=\"4063\"\u003e\n\u003ctr data-start=\"4021\" data-end=\"4063\"\u003e\n\u003cth data-start=\"4021\" data-end=\"4031\" data-col-size=\"sm\"\u003ePathway\u003c\/th\u003e\n\u003cth data-start=\"4031\" data-end=\"4052\" data-col-size=\"sm\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-start=\"4052\" data-end=\"4063\" data-col-size=\"sm\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"4078\" data-end=\"4474\"\u003e\n\u003ctr data-start=\"4078\" data-end=\"4150\"\u003e\n\u003ctd data-start=\"4078\" data-end=\"4106\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4080\" data-end=\"4105\"\u003eNADPH-MetHb reductase\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4106\" data-end=\"4129\"\u003eRestores O₂ carriage\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4129\" data-end=\"4150\"\u003eMethemoglobinemia\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4151\" data-end=\"4235\"\u003e\n\u003ctd data-start=\"4151\" data-end=\"4174\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4153\" data-end=\"4173\"\u003eNO–sGC–cGMP axis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4174\" data-end=\"4205\"\u003e↑ MAP, vasoconstrictive tone\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4205\" data-end=\"4235\"\u003eVasoplegic shock, priapism\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4236\" data-end=\"4313\"\u003e\n\u003ctd data-start=\"4236\" data-end=\"4259\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4238\" data-end=\"4258\"\u003eMAO-A inhibition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4259\" data-end=\"4293\"\u003e↑ synaptic monoamines; DDI risk\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4293\" data-end=\"4313\"\u003eCNS\/pharmacology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4314\" data-end=\"4392\"\u003e\n\u003ctd data-start=\"4314\" data-end=\"4339\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4316\" data-end=\"4338\"\u003eETC bypass (redox)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4339\" data-end=\"4354\"\u003e↑ ATP, ↓ ROS\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4354\" data-end=\"4392\"\u003eNeuro\/retina, ischemia–reperfusion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4393\" data-end=\"4474\"\u003e\n\u003ctd data-start=\"4393\" data-end=\"4416\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4395\" data-end=\"4415\"\u003eaPDT (ROS burst)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4416\" data-end=\"4452\"\u003eRapid microbicidal \u0026amp; anti-biofilm\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"4452\" data-end=\"4474\"\u003eWounds, dental\/ENT\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"4476\" data-end=\"4479\"\u003e\n\u003ch2 data-start=\"4481\" data-end=\"4503\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-start=\"4505\" data-end=\"5047\"\u003e\n\u003cli data-start=\"4505\" data-end=\"4677\"\u003e\n\u003cp data-start=\"4507\" data-end=\"4677\"\u003e\u003cstrong data-start=\"4507\" data-end=\"4518\"\u003eRoutes:\u003c\/strong\u003e \u003cstrong data-start=\"4519\" data-end=\"4525\"\u003eIV\u003c\/strong\u003e (methemoglobinemia, vasoplegia), \u003cstrong data-start=\"4559\" data-end=\"4567\"\u003eoral\u003c\/strong\u003e (historical\/adjunct), \u003cstrong data-start=\"4590\" data-end=\"4601\"\u003etopical\u003c\/strong\u003e, \u003cstrong data-start=\"4603\" data-end=\"4622\"\u003eintracavernosal\u003c\/strong\u003e (rescue), \u003cstrong data-start=\"4633\" data-end=\"4651\"\u003eintranasal\/neb\u003c\/strong\u003e (investigational aPDT).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4678\" data-end=\"4730\"\u003e\n\u003cp data-start=\"4680\" data-end=\"4730\"\u003e\u003cstrong data-start=\"4680\" data-end=\"4690\"\u003eOnset:\u003c\/strong\u003e IV \u003cstrong data-start=\"4694\" data-end=\"4705\"\u003eminutes\u003c\/strong\u003e for MetHb\/MAP effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4731\" data-end=\"4804\"\u003e\n\u003cp data-start=\"4733\" data-end=\"4804\"\u003e\u003cstrong data-start=\"4733\" data-end=\"4747\"\u003eHalf-life:\u003c\/strong\u003e Biphasic; reports \u003cstrong data-start=\"4766\" data-end=\"4777\"\u003e~5–24 h\u003c\/strong\u003e (formulation-dependent).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4805\" data-end=\"4966\"\u003e\n\u003cp data-start=\"4807\" data-end=\"4966\"\u003e\u003cstrong data-start=\"4807\" data-end=\"4842\"\u003eDistribution\/biotransformation:\u003c\/strong\u003e Rapid tissue distribution; \u003cstrong data-start=\"4870\" data-end=\"4893\"\u003ereduced to leuco-MB\u003c\/strong\u003e intracellularly; \u003cstrong data-start=\"4911\" data-end=\"4930\"\u003erenal excretion\u003c\/strong\u003e(blue-green urine), some biliary.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4967\" data-end=\"5047\"\u003e\n\u003cp data-start=\"4969\" data-end=\"5047\"\u003e\u003cstrong data-start=\"4969\" data-end=\"4993\"\u003eDevice interference:\u003c\/strong\u003e Transient \u003cstrong data-start=\"5004\" data-end=\"5026\"\u003eSpO₂ under-reading\u003c\/strong\u003e (absorbs at 660 nm).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5049\" data-end=\"5052\"\u003e\n\u003ch2 data-start=\"5054\" data-end=\"5099\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-start=\"5101\" data-end=\"5131\"\u003e4.1 Vasoplegic Syndromes\u003c\/h3\u003e\n\u003cp data-start=\"5132\" data-end=\"5356\"\u003eIn sepsis and post-cardiopulmonary-bypass vasoplegia, MB \u003cstrong data-start=\"5189\" data-end=\"5205\"\u003eimproves MAP\u003c\/strong\u003e and \u003cstrong data-start=\"5210\" data-end=\"5239\"\u003ereduces vasopressor needs\u003c\/strong\u003e; timing (early vs rescue), dose, and patient selection are key determinants; outcome effects are under active study.\u003c\/p\u003e\n\u003ch3 data-start=\"5358\" data-end=\"5394\"\u003e4.2 Oncology\/Neurodegeneration\u003c\/h3\u003e\n\u003cp data-start=\"5395\" data-end=\"5564\"\u003e\u003cstrong data-start=\"5395\" data-end=\"5412\"\u003eTau-targeting\u003c\/strong\u003e LMTM programs show \u003cstrong data-start=\"5432\" data-end=\"5462\"\u003edose\/formulation-dependent\u003c\/strong\u003e cognitive outcomes; mitochondrial support and anti-aggregation continue to be explored in \u003cstrong data-start=\"5553\" data-end=\"5563\"\u003eAD\/FTD\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-start=\"5566\" data-end=\"5595\"\u003e4.3 Anti-infective aPDT\u003c\/h3\u003e\n\u003cp data-start=\"5596\" data-end=\"5812\"\u003eTopical\/oral cavity \u003cstrong data-start=\"5616\" data-end=\"5627\"\u003eMB-aPDT\u003c\/strong\u003e clears biofilms, reduces \u003cstrong data-start=\"5653\" data-end=\"5693\"\u003eperi-implant mucositis\/periodontitis\u003c\/strong\u003e indices, and accelerates \u003cstrong data-start=\"5719\" data-end=\"5748\"\u003echronic-wound granulation\u003c\/strong\u003e; standardized dosing and light fluence remain to be harmonized.\u003c\/p\u003e\n\u003ch3 data-start=\"5814\" data-end=\"5858\"\u003e4.4 Ifosfamide Encephalopathy \u0026amp; Others\u003c\/h3\u003e\n\u003cp data-start=\"5859\" data-end=\"6027\"\u003eObservational cohorts report \u003cstrong data-start=\"5888\" data-end=\"5911\"\u003eneurologic recovery\u003c\/strong\u003e after MB in IIE; additional uses include \u003cstrong data-start=\"5953\" data-end=\"5972\"\u003epriapism rescue\u003c\/strong\u003e, \u003cstrong data-start=\"5974\" data-end=\"5999\"\u003esentinel-node mapping\u003c\/strong\u003e, and \u003cstrong data-start=\"6005\" data-end=\"6026\"\u003eurologic staining\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cblockquote data-start=\"6029\" data-end=\"6224\"\u003e\n\u003cp data-start=\"6031\" data-end=\"6224\"\u003e\u003cstrong data-start=\"6031\" data-end=\"6057\"\u003eEvidence quality note:\u003c\/strong\u003e Robust for \u003cstrong data-start=\"6069\" data-end=\"6090\"\u003emethemoglobinemia\u003c\/strong\u003e; \u003cstrong data-start=\"6092\" data-end=\"6118\"\u003emoderate\/heterogeneous\u003c\/strong\u003e for vasoplegia and IIE (controlled but small); \u003cstrong data-start=\"6166\" data-end=\"6178\"\u003eemerging\u003c\/strong\u003e for aPDT, dermatology, and neurodegeneration.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-start=\"6226\" data-end=\"6229\"\u003e\n\u003ch2 data-start=\"6231\" data-end=\"6264\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"6266\" data-end=\"6975\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"6266\" data-end=\"6304\"\u003e\n\u003ctr data-start=\"6266\" data-end=\"6304\"\u003e\n\u003cth data-start=\"6266\" data-end=\"6274\" data-col-size=\"sm\"\u003eField\u003c\/th\u003e\n\u003cth data-start=\"6274\" data-end=\"6286\" data-col-size=\"sm\"\u003eRationale\u003c\/th\u003e\n\u003cth data-start=\"6286\" data-end=\"6304\" data-col-size=\"sm\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"6319\" data-end=\"6975\"\u003e\n\u003ctr data-start=\"6319\" data-end=\"6439\"\u003e\n\u003ctd data-start=\"6319\" data-end=\"6360\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6321\" data-end=\"6359\"\u003eVasoplegic shock (sepsis\/post-CPB)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6360\" data-end=\"6400\"\u003esGC blockade complements vasopressors\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6400\" data-end=\"6439\"\u003eRCTs\/series; practice heterogeneity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6440\" data-end=\"6527\"\u003e\n\u003ctd data-start=\"6440\" data-end=\"6472\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6442\" data-end=\"6471\"\u003eIfosfamide encephalopathy\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6472\" data-end=\"6493\"\u003eRedox\/MAO pathways\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6493\" data-end=\"6527\"\u003eProtocolized rescue in centers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6528\" data-end=\"6637\"\u003e\n\u003ctd data-start=\"6528\" data-end=\"6557\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6530\" data-end=\"6556\"\u003eAlzheimer’s\/FTD (LMTM)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6557\" data-end=\"6598\"\u003eTau inhibition + mitochondrial support\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6598\" data-end=\"6637\"\u003eMixed trials; next-gen formulations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6638\" data-end=\"6732\"\u003e\n\u003ctd data-start=\"6638\" data-end=\"6676\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6640\" data-end=\"6675\"\u003eChronic wounds\/dentistry (aPDT)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6676\" data-end=\"6705\"\u003eAnti-biofilm + pro-healing\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6705\" data-end=\"6732\"\u003eEarly clinical adoption\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6733\" data-end=\"6819\"\u003e\n\u003ctd data-start=\"6733\" data-end=\"6769\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6735\" data-end=\"6768\"\u003eRetinal\/optic neuroprotection\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6769\" data-end=\"6792\"\u003eETC bypass, anti-ROS\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6792\" data-end=\"6819\"\u003eSmall human\/mechanistic\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6820\" data-end=\"6903\"\u003e\n\u003ctd data-start=\"6820\" data-end=\"6847\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6822\" data-end=\"6846\"\u003eAntimalarial partner\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6847\" data-end=\"6884\" data-col-size=\"sm\"\u003eGametocyte kill\/transmission block\u003c\/td\u003e\n\u003ctd data-start=\"6884\" data-end=\"6903\" data-col-size=\"sm\"\u003eRegional trials\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6904\" data-end=\"6975\"\u003e\n\u003ctd data-start=\"6904\" data-end=\"6932\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6906\" data-end=\"6931\"\u003ePriapism (refractory)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6932\" data-end=\"6952\" data-col-size=\"sm\"\u003eNO–sGC inhibition\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6952\" data-end=\"6975\"\u003eSalvage case series\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"6977\" data-end=\"6980\"\u003e\n\u003ch2 data-start=\"6982\" data-end=\"7011\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-start=\"7013\" data-end=\"7899\"\u003e\n\u003cli data-start=\"7013\" data-end=\"7129\"\u003e\n\u003cp data-start=\"7015\" data-end=\"7129\"\u003e\u003cstrong data-start=\"7015\" data-end=\"7026\"\u003eCommon:\u003c\/strong\u003e \u003cstrong data-start=\"7027\" data-end=\"7047\"\u003eBlue\/green urine\u003c\/strong\u003e, \u003cstrong data-start=\"7049\" data-end=\"7070\"\u003eskin\/scleral tint\u003c\/strong\u003e, \u003cstrong data-start=\"7072\" data-end=\"7082\"\u003enausea\u003c\/strong\u003e, \u003cstrong data-start=\"7084\" data-end=\"7097\"\u003edizziness\u003c\/strong\u003e, \u003cstrong data-start=\"7099\" data-end=\"7111\"\u003eheadache\u003c\/strong\u003e, \u003cstrong data-start=\"7113\" data-end=\"7126\"\u003edysgeusia\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7130\" data-end=\"7269\"\u003e\n\u003cp data-start=\"7132\" data-end=\"7269\"\u003e\u003cstrong data-start=\"7132\" data-end=\"7147\"\u003eHematology:\u003c\/strong\u003e \u003cstrong data-start=\"7148\" data-end=\"7185\"\u003eHemolysis risk in G6PD deficiency\u003c\/strong\u003e; screen when feasible. High doses can \u003cstrong data-start=\"7224\" data-end=\"7252\"\u003eworsen methemoglobinemia\u003c\/strong\u003e (paradoxical).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7270\" data-end=\"7423\"\u003e\n\u003cp data-start=\"7272\" data-end=\"7423\"\u003e\u003cstrong data-start=\"7272\" data-end=\"7299\"\u003eNeurologic\/psychiatric:\u003c\/strong\u003e \u003cstrong data-start=\"7300\" data-end=\"7322\"\u003eSerotonin syndrome\u003c\/strong\u003e possible with \u003cstrong data-start=\"7337\" data-end=\"7383\"\u003eSSRIs\/SNRIs\/MAOIs\/linezolid\/tramadol, etc.\u003c\/strong\u003e (MB is a \u003cstrong data-start=\"7393\" data-end=\"7419\"\u003epotent MAO-A inhibitor\u003c\/strong\u003e).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7424\" data-end=\"7545\"\u003e\n\u003cp data-start=\"7426\" data-end=\"7545\"\u003e\u003cstrong data-start=\"7426\" data-end=\"7445\"\u003eCardiovascular:\u003c\/strong\u003e \u003cstrong data-start=\"7446\" data-end=\"7459\"\u003e↑ SVR\/MAP\u003c\/strong\u003e desired in vasoplegia; watch for \u003cstrong data-start=\"7493\" data-end=\"7518\"\u003ehypertension\/ischemia\u003c\/strong\u003e in susceptible patients.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7546\" data-end=\"7624\"\u003e\n\u003cp data-start=\"7548\" data-end=\"7624\"\u003e\u003cstrong data-start=\"7548\" data-end=\"7562\"\u003ePulmonary:\u003c\/strong\u003e Can transiently \u003cstrong data-start=\"7579\" data-end=\"7602\"\u003elower SpO₂ readings\u003c\/strong\u003e (optical artifact).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7625\" data-end=\"7741\"\u003e\n\u003cp data-start=\"7627\" data-end=\"7741\"\u003e\u003cstrong data-start=\"7627\" data-end=\"7650\"\u003ePregnancy\/Neonates:\u003c\/strong\u003e \u003cstrong data-start=\"7651\" data-end=\"7660\"\u003eAvoid\u003c\/strong\u003e—risk of \u003cstrong data-start=\"7669\" data-end=\"7720\"\u003efetal\/neonatal hemolysis and hyperbilirubinemia\u003c\/strong\u003e; crosses placenta.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7742\" data-end=\"7899\"\u003e\n\u003cp data-start=\"7744\" data-end=\"7899\"\u003e\u003cstrong data-start=\"7744\" data-end=\"7770\"\u003eDosing considerations:\u003c\/strong\u003e Typical IV \u003cstrong data-start=\"7782\" data-end=\"7795\"\u003e1–2 mg\/kg\u003c\/strong\u003e (slow push\/infusion) with \u003cstrong data-start=\"7822\" data-end=\"7839\"\u003erepeat dosing\u003c\/strong\u003e per protocol; monitor \u003cstrong data-start=\"7862\" data-end=\"7871\"\u003eMetHb\u003c\/strong\u003e, \u003cstrong data-start=\"7873\" data-end=\"7880\"\u003eABG\u003c\/strong\u003e, \u003cstrong data-start=\"7882\" data-end=\"7898\"\u003ehemodynamics\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"7901\" data-end=\"7951\"\u003e\u003cstrong data-start=\"7901\" data-end=\"7951\"\u003eComparative safety matrix (vasoplegia context)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"7953\" data-end=\"8549\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"7953\" data-end=\"8026\"\u003e\n\u003ctr data-start=\"7953\" data-end=\"8026\"\u003e\n\u003cth data-start=\"7953\" data-end=\"7963\" data-col-size=\"sm\"\u003eConcern\u003c\/th\u003e\n\u003cth data-start=\"7963\" data-end=\"7984\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"7965\" data-end=\"7983\"\u003eMethylene blue\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"7984\" data-end=\"8007\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"7986\" data-end=\"8006\"\u003eHydroxocobalamin\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"8007\" data-end=\"8026\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8009\" data-end=\"8024\"\u003eVasopressin\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"8045\" data-end=\"8549\"\u003e\n\u003ctr data-start=\"8045\" data-end=\"8141\"\u003e\n\u003ctd data-start=\"8045\" data-end=\"8065\" data-col-size=\"sm\"\u003ePrimary mechanism\u003c\/td\u003e\n\u003ctd data-start=\"8065\" data-end=\"8090\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"8067\" data-end=\"8089\"\u003eNOS\/sGC inhibition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"8090\" data-end=\"8118\" data-col-size=\"md\"\u003e\n\u003cstrong data-start=\"8092\" data-end=\"8108\"\u003eNO scavenger\u003c\/strong\u003e (cobalt)\u003c\/td\u003e\n\u003ctd data-start=\"8118\" data-end=\"8141\" data-col-size=\"sm\"\u003eV1 receptor agonist\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"8142\" data-end=\"8262\"\u003e\n\u003ctd data-start=\"8142\" data-end=\"8158\" data-col-size=\"sm\"\u003eEffect on MAP\u003c\/td\u003e\n\u003ctd data-start=\"8158\" data-end=\"8195\" data-col-size=\"md\"\u003eRapid ↑; \u003cstrong data-start=\"8169\" data-end=\"8194\"\u003ecatecholamine-sparing\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd data-start=\"8195\" data-end=\"8228\" data-col-size=\"md\"\u003eRapid ↑; catecholamine-sparing\u003c\/td\u003e\n\u003ctd data-start=\"8228\" data-end=\"8262\" data-col-size=\"sm\"\u003e↑ SVR with low arrhythmia risk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"8263\" data-end=\"8431\"\u003e\n\u003ctd data-start=\"8263\" data-end=\"8275\" data-col-size=\"sm\"\u003eKey risks\u003c\/td\u003e\n\u003ctd data-start=\"8275\" data-end=\"8327\" data-col-size=\"md\"\u003e\n\u003cstrong data-start=\"8277\" data-end=\"8291\"\u003eMAO-A DDIs\u003c\/strong\u003e, \u003cstrong data-start=\"8293\" data-end=\"8311\"\u003eG6PD hemolysis\u003c\/strong\u003e, SpO₂ artifact\u003c\/td\u003e\n\u003ctd data-start=\"8327\" data-end=\"8392\" data-col-size=\"md\"\u003e\n\u003cstrong data-start=\"8329\" data-end=\"8344\"\u003eChromaturia\u003c\/strong\u003e, potential \u003cstrong data-start=\"8356\" data-end=\"8367\"\u003eoxalate\u003c\/strong\u003e, interference with labs\u003c\/td\u003e\n\u003ctd data-start=\"8392\" data-end=\"8431\" data-col-size=\"sm\"\u003eIschemia at high dose, hyponatremia\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"8432\" data-end=\"8549\"\u003e\n\u003ctd data-start=\"8432\" data-end=\"8448\" data-col-size=\"sm\"\u003eSpecial notes\u003c\/td\u003e\n\u003ctd data-start=\"8448\" data-end=\"8484\" data-col-size=\"md\"\u003eCan \u003cstrong data-start=\"8454\" data-end=\"8470\"\u003eworsen MetHb\u003c\/strong\u003e at high dose\u003c\/td\u003e\n\u003ctd data-start=\"8484\" data-end=\"8517\" data-col-size=\"md\"\u003eUseful when MB contraindicated\u003c\/td\u003e\n\u003ctd data-start=\"8517\" data-end=\"8549\" data-col-size=\"sm\"\u003eSynergizes with MB in rescue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"8551\" data-end=\"8554\"\u003e\n\u003ch2 data-start=\"8556\" data-end=\"8582\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-start=\"8584\" data-end=\"8990\"\u003e\n\u003cli data-start=\"8584\" data-end=\"8649\"\u003e\n\u003cp data-start=\"8586\" data-end=\"8649\"\u003e\u003cstrong data-start=\"8586\" data-end=\"8599\"\u003eApproved:\u003c\/strong\u003e \u003cstrong data-start=\"8600\" data-end=\"8630\"\u003eAcquired methemoglobinemia\u003c\/strong\u003e (parenteral MB).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8650\" data-end=\"8781\"\u003e\n\u003cp data-start=\"8652\" data-end=\"8781\"\u003e\u003cstrong data-start=\"8652\" data-end=\"8673\"\u003eCommon off-label:\u003c\/strong\u003e \u003cstrong data-start=\"8674\" data-end=\"8694\"\u003eVasoplegic shock\u003c\/strong\u003e, \u003cstrong data-start=\"8696\" data-end=\"8725\"\u003eifosfamide encephalopathy\u003c\/strong\u003e, \u003cstrong data-start=\"8727\" data-end=\"8746\"\u003epriapism rescue\u003c\/strong\u003e, \u003cstrong data-start=\"8748\" data-end=\"8756\"\u003eaPDT\u003c\/strong\u003e (topical\/oral cavity).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8782\" data-end=\"8885\"\u003e\n\u003cp data-start=\"8784\" data-end=\"8885\"\u003e\u003cstrong data-start=\"8784\" data-end=\"8804\"\u003eInvestigational:\u003c\/strong\u003e \u003cstrong data-start=\"8805\" data-end=\"8827\"\u003eTau-targeting LMTM\u003c\/strong\u003e, \u003cstrong data-start=\"8829\" data-end=\"8856\"\u003eretinal neuroprotection\u003c\/strong\u003e, \u003cstrong data-start=\"8858\" data-end=\"8882\"\u003eantimalarial partner\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8886\" data-end=\"8990\"\u003e\n\u003cp data-start=\"8888\" data-end=\"8990\"\u003e\u003cstrong data-start=\"8888\" data-end=\"8899\"\u003eSupply:\u003c\/strong\u003e Use \u003cstrong data-start=\"8904\" data-end=\"8920\"\u003eGMP-grade MB\u003c\/strong\u003e (sterile, USP) for IV; compounded\/non-sterile dyes are \u003cstrong data-start=\"8976\" data-end=\"8986\"\u003eunsafe\u003c\/strong\u003e IV.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"8992\" data-end=\"8995\"\u003e\n\u003ch2 data-start=\"8997\" data-end=\"9020\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-start=\"9022\" data-end=\"9635\"\u003e\n\u003cli data-start=\"9022\" data-end=\"9164\"\u003e\n\u003cp data-start=\"9024\" data-end=\"9164\"\u003e\u003cstrong data-start=\"9024\" data-end=\"9056\"\u003ePrecision use in vasoplegia:\u003c\/strong\u003e Timing (early vs rescue), \u003cstrong data-start=\"9083\" data-end=\"9100\"\u003edose–response\u003c\/strong\u003e, and \u003cstrong data-start=\"9106\" data-end=\"9129\"\u003ephenotype selection\u003c\/strong\u003e (e.g., high NO\/cGMP signatures).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9165\" data-end=\"9291\"\u003e\n\u003cp data-start=\"9167\" data-end=\"9291\"\u003e\u003cstrong data-start=\"9167\" data-end=\"9189\"\u003eNeurodegeneration:\u003c\/strong\u003e Optimize \u003cstrong data-start=\"9199\" data-end=\"9224\"\u003eLMTM pharmacokinetics\u003c\/strong\u003e and identify \u003cstrong data-start=\"9238\" data-end=\"9278\"\u003etau-positive, monotherapy-responsive\u003c\/strong\u003esubgroups.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9292\" data-end=\"9408\"\u003e\n\u003cp data-start=\"9294\" data-end=\"9408\"\u003e\u003cstrong data-start=\"9294\" data-end=\"9315\"\u003eStandardize aPDT:\u003c\/strong\u003e Dose, \u003cstrong data-start=\"9322\" data-end=\"9333\"\u003efluence\u003c\/strong\u003e, and \u003cstrong data-start=\"9339\" data-end=\"9351\"\u003eoutcomes\u003c\/strong\u003e for wounds\/dentistry\/ENT; head-to-head vs antibiotics.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9409\" data-end=\"9510\"\u003e\n\u003cp data-start=\"9411\" data-end=\"9510\"\u003e\u003cstrong data-start=\"9411\" data-end=\"9438\"\u003eMitochondrial medicine:\u003c\/strong\u003e Define \u003cstrong data-start=\"9446\" data-end=\"9461\"\u003edose window\u003c\/strong\u003e for ETC support without MAO-A adverse effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9511\" data-end=\"9635\"\u003e\n\u003cp data-start=\"9513\" data-end=\"9635\"\u003e\u003cstrong data-start=\"9513\" data-end=\"9535\"\u003eSafety registries:\u003c\/strong\u003e \u003cstrong data-start=\"9536\" data-end=\"9558\"\u003eSerotonin-syndrome\u003c\/strong\u003e pharmacovigilance; \u003cstrong data-start=\"9578\" data-end=\"9586\"\u003eG6PD\u003c\/strong\u003e screening pathways; pregnancy\/neonatal outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"9637\" data-end=\"9640\"\u003e\n\u003ch3 data-start=\"9642\" data-end=\"9665\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-start=\"9667\" data-end=\"10501\"\u003e\n\u003cli data-start=\"9667\" data-end=\"9765\"\u003e\n\u003cp data-start=\"9669\" data-end=\"9765\"\u003e\u003cstrong data-start=\"9669\" data-end=\"9702\"\u003eAnesthesiology; Critical Care\u003c\/strong\u003e — Vasoplegic shock trials\/series with MB (post-CPB, sepsis).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9766\" data-end=\"9885\"\u003e\n\u003cp data-start=\"9768\" data-end=\"9885\"\u003e\u003cstrong data-start=\"9768\" data-end=\"9827\"\u003eJournal of Clinical Oncology; Supportive Care in Cancer\u003c\/strong\u003e — Ifosfamide-induced encephalopathy reversal protocols.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9886\" data-end=\"9988\"\u003e\n\u003cp data-start=\"9888\" data-end=\"9988\"\u003e\u003cstrong data-start=\"9888\" data-end=\"9944\"\u003eThe Lancet Neurology; Journal of Alzheimer’s Disease\u003c\/strong\u003e — LMTM (methylthioninium) in tauopathies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9989\" data-end=\"10079\"\u003e\n\u003cp data-start=\"9991\" data-end=\"10079\"\u003e\u003cstrong data-start=\"9991\" data-end=\"10014\"\u003ePNAS; Redox Biology\u003c\/strong\u003e — Mitochondrial electron-shuttling and antioxidant properties.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10080\" data-end=\"10199\"\u003e\n\u003cp data-start=\"10082\" data-end=\"10199\"\u003e\u003cstrong data-start=\"10082\" data-end=\"10157\"\u003eAntimicrobial Agents \u0026amp; Chemotherapy; Journal of Clinical Periodontology\u003c\/strong\u003e — MB-mediated aPDT in wounds\/dentistry.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10200\" data-end=\"10320\"\u003e\n\u003cp data-start=\"10202\" data-end=\"10320\"\u003e\u003cstrong data-start=\"10202\" data-end=\"10253\"\u003eThe Lancet Infectious Diseases; Malaria Journal\u003c\/strong\u003e — MB as an antimalarial partner and transmission-blocking agent.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10321\" data-end=\"10414\"\u003e\n\u003cp data-start=\"10323\" data-end=\"10414\"\u003e\u003cstrong data-start=\"10323\" data-end=\"10371\"\u003eInvestigative Ophthalmology \u0026amp; Visual Science\u003c\/strong\u003e — Retinal\/optic neuroprotection studies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10415\" data-end=\"10501\"\u003e\n\u003cp data-start=\"10417\" data-end=\"10501\"\u003e\u003cstrong data-start=\"10417\" data-end=\"10447\"\u003eUrology; BJU International\u003c\/strong\u003e — MB for refractory priapism via NO–sGC inhibition.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":52684866814290,"sku":null,"price":60.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/Methylene_Blue_10mg.png?v=1770834950","url":"https:\/\/sciencepeptideslab.com\/products\/methylene-blue-60ml-usp-grade","provider":"Science Peptides Lab","version":"1.0","type":"link"}